EN | UA
EN | UA

Help Support

Back

Treatment of Drug-Induced Peripheral Neuropathy

Treatment of Drug-Induced Peripheral Neuropathy Treatment of Drug-Induced Peripheral Neuropathy
Treatment of Drug-Induced Peripheral Neuropathy Treatment of Drug-Induced Peripheral Neuropathy

What's new?

Drug induced peripheral neuropathy (DIPN) accounts for only 4% of all neuropathies, and about 60% of patients undergoing chemotherapy have the chance to develop DIPN.

A recently published narrative review in 'Current Clinical Pharmacology' illustrated the treatment options for drug-induced peripheral neuropathy (DIPN).


Peripheral neuropathy is a distressing ailment with various etiologies and specific medications have found to be associated with the development of DIPN. These include antimicrobials, chemotherapeutic agents, anticonvulsants, cardiovascular drugs, psychotropic etc. DIPN has shown to be developed in a dose-dependent fashion after the continued use of a neurotoxic agent in many cases. DIPN development should be suspected in patients who are receiving drug treatment and report the new onset symptoms of pain, paresthesia, or weakness. The motor and sensory nerve conduction studies may support the clinical diagnosis in patients in whom a history of DIPN is doubted. The occurrence of DIPN becomes even more prevalent in patients with risk factors such as diabetes, pre-existing neuropathy or genetically predisposing diseases. Often, DIPN is challenging to treat, but medications like duloxetine and gabapentin have been proved to decrease the neuropathic pain. The advanced techniques of neuromodulation are quite promising but more randomised and controlled studies are required in future to confirm the efficacy of them.

Source:

Current Clinical Pharmacology

Article:

Drug-Induced Peripheral Neuropathy, a Narrative Review

Authors:

Jones MR et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: